Navigating patient-reported outcomes (PROs) such as symptoms, treatment satisfaction, quality of life, and treatment adherence is a critical component of a patient-centric healthcare system. Increasingly, PROs are becoming a crucial element in the decision process for payers, providers — and even for securing FDA approval. But how can PROs advance healthcare and how can your organization put them to use?

Join Cardinal Health experts in the second of our three-part webinar series, as we review the qualitative phase of PRO instrument development within the context of an individual drug development program, PRO instrument modification and regulatory requirements associated with development of these measures for specific populations.

Key objectives for this webinar include:

  • Understanding how to develop effective concept elicitation methods and cognitive interview strategies to support the validity of a PRO instrument
  • Defining and appropriately collecting data to support PRO instrument modifications in the context of an individual development program
  • Reviewing regulatory mandates for the development of pediatric-specific PRO instruments and strategies for instrument evaluation within this population

Featured Speakers

Todd Phillips, PharmD, RAC

Director, Global Regulatory Affairs
Cardinal Health Regulatory Sciences

Todd Phillips, PharmD, RAC, is Director of Global Regulatory Affairs for Cardinal Health Regulatory Sciences. Dr. Phillips provides strategic development and regulatory consulting services to a variety of drug and biological product manufacturers. He has more than 15 years of experience in regulatory affairs, drug development, clinical project management and product marketing. 

Eli G. Phillips, Jr., PharmD, JD

Vice President, Insights & Engagement
Cardinal Health Specialty Solutions

Eli Phillips, Jr., PharmD, JD is Vice-President for Insights & Engagement within Cardinal Health Specialty Solutions. Dr. Phillips is responsible for the strategy, growth, and financial performance of Insights and Engagement, which provides a wide range of services for the pharmaceutical industry, including: health economics and outcomes research, synthesis and analysis of real world evidence, and commercial marketing through provider engagement. 

NOW AVAILABLE ON-DEMAND

Register now for this webinar